| Literature DB >> 35614202 |
Karime Tavares Lima da Silva1,2, Renata Grazziotin-Soares3, Rafael Resende de Miranda4, Veridiana Resende Novais1,4, Edilausson Moreno Carvalho1, Gisele Rodrigues da Silva1,4, Jose Bauer5, Ceci Nunes Carvalho6.
Abstract
The advantage of using an Enamel matrix derivative EMD Emdogain as an intracanal medication could be a manner to strength the tooth structure, improving the physical and chemical properties of dentin. We tested, in vitro, the effect of Emdogain on the surface microhardness and chemical composition of root dentin. Ten human teeth were used to produce dentin specimens originated from the canal walls (n = 30) that remained in contact to Emdogain gel for 90 days. Baseline and 90-days after Emdogain treatment measurements were performed using Fourier Transform Infrared Spectroscopy (ATR/FTIR), Scanning Electron Microscopy/Energy Dispersive Spectroscopy (SEM/EDS) and Knoop indenters. The use of EMD (Emdogain) for 90 days in contact with human root canal dentin specimens did not alter the microhardness and morphology of dentin. The elemental structure of dentin was altered because there was a reduction in carbonate content.Entities:
Mesh:
Year: 2022 PMID: 35614202 PMCID: PMC9133032 DOI: 10.1038/s41598-022-13081-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Schematic illustration of the experimental design.
Mean and standard deviation (SD) of Knoop Dentin Microhardness (KMH); and mean and SD of the integrated area of each chemical component, as well as ratios (M:M; C:M, amide I/amide III and amide I/CH2) analyzed by FTIR before and 90-days after EMD (Emdogain) treatment.
| Before EDM treatment (baseline) | After EDM treatment | p-value | |
|---|---|---|---|
| Dentin microhardness | 53.2 (10.1) | 49.5 (12.1) | = 0.35 |
| Phosphate | 13.15 (1.30) | 11.95 (1.79) | = 0.103 |
| Carbonate | 0.23 (0.03) | 0.16 (0.03) | = 0.001* |
| Amide I | 2.06 (0.36) | 2.22 (0.73) | = 0.685 |
| Amide III | 0.22 (0.05) | 0.16 (0.02) | = 0.002* |
| CH2 | 0.12 (0.04) | 0.14 (0.05) | = 0.395 |
| M:M | 6.58 (1.40) | 5.72 (1.46) | = 0.293 |
| C:M | 0.017 (0.001) | 0.013 (0.001) | < 0.001** |
| Amide I/amide III | 9.70 (1.38) | 12.71 (1.71) | < 0.001** |
| Amide I/CH2 | 17.94 (4.43) | 17.50 (6.42) | = 0.857 |
*Indicates differences in root dentin chemical components (in rows) obtained by paired t-test (p < 0.05).
**Indicates differences in root dentin ratios (in rows) obtained by paired t-test (p < 0.05).
Figure 2(A) Representative imagens of dentinal surface FTIR spectra before EMD (Emdogain) treatment. (B) Representative images/spectra of FTIR spectra after EMD (Emdogain) treatment. Specimens` surface from the same sample analysed by SEM/EDS: (C) is showing the SEM image and the spectra (right side) before treatment with EMD (Emdogain) (baseline); and (D) is showing the SEM image and the spectra (right side) 90-days after treatment with EMD (Emdogain).